FindTrial
Sign In

Efficacy of Medicated Ghee Consumption in Psychiatric Disorders

An Observational Study ON THE Efficacy of Arohana Snehapana and Shodhana Therapy in General Psychiatric Disorders - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/074745
Enrollment
73
Registered
2024-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence Health Condition 2: F320- Major depressive disorder, singleepisode, mild Health Condition 3: F200- Paranoid schizophrenia

Interventions

None listed

Sponsors

Kavyanjali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Cases of All Kinds of Psychiatric Diseases All Participants Registered Under Manasaroga and Undergoing Arohana Snehapana

Exclusion criteria

Exclusion criteria: Pregnant Women Participants Who Cannot Comprehend the Questions Asked in the Interview

Design outcomes

Primary

MeasureTime frame
Efficacy of Increasing Dosages of Snehapana in General Psychiatric DisordersTimepoint: Two scales are Used to Assess the Effect those are Depression Anxiety Stress Scale and Positive and Negative Syndrome Scale Everyday During Snehapana Scales are Applied and Scores are Noted Down and at the End of Virechana Procedure also Scores are Noted Down it will be there for 6 to 12 days—

Secondary

MeasureTime frame
Improvement in Psychiatric SymptomsTimepoint: 6-10 days—

Countries

India

Contacts

Public ContactDr Savitha HP

Department of Manasaroga Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

savithem@gmail.com9980168208

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026